**Question:** A 50-year-old male with type 2 diabetes mellitus is found to have 24-hr urinary albumin of 250 mg. Which of the following drugs may be used to retard the progression of the renal disease -

A. ACE inhibitors (Enalapril, Ramipril)
B. Angiotensin II receptor blockers (Losartan)
C. Thiazide diuretics (HCTZ)
D. Glucocorticoids (Cortisol)

**Correct Answer:**

**Core Concept:**

The progression of diabetic nephropathy, a common complication of type 2 diabetes, can be slowed down using specific medications targeting the renin-angiotensin-aldosterone system (RAAS). Diabetic nephropathy results in increased urinary albumin excretion (UAE), which indicates kidney damage.

**Why the Correct Answer is Right:**

1. ACE inhibitors (Enalapril, Ramipril) work by inhibiting the conversion of angiotensin I to angiotensin II, a potent vasoconstrictor and aldosterone stimulator. This leads to a decrease in UAE and retards the progression of diabetic nephropathy.
2. Angiotensin II receptor blockers (Losartan) also work by blocking angiotensin II action, reducing UAE, and slowing down diabetic nephropathy progression.
3. Thiazide diuretics (HCTZ) are diuretics that reduce blood pressure and fluid overload, but they do not target the RAAS or UAE. Therefore, they are not effective in retarding diabetic nephropathy progression.
4. Glucocorticoids (Cortisol) are anti-inflammatory and immunosuppressive agents used in autoimmune and inflammatory conditions. They are not specific to renal disease and do not retard the progression of diabetic nephropathy.

**Why Each Wrong Option is Incorrect:**

**Option A (ACE inhibitors):**
- ACE inhibitors are the preferred pharmacological choice for diabetic nephropathy management due to their specific targeting of the RAAS and UAE reduction.

**Option B (Angiotensin II receptor blockers):**
- Losartan and other angiotensin II receptor blockers also block angiotensin II action, reducing UAE, and slowing down diabetic nephropathy progression.

**Option C (Thiazide diuretics):**
- These medications primarily target blood pressure and fluid overload, but do not directly affect UAE or the RAAS system, so they are not effective in retarding diabetic nephropathy progression.

**Option D (Glucocorticoids):**
- Glucocorticoids are used in autoimmune and inflammatory conditions and do not specifically target diabetic nephropathy or reduce UAE.

**Core Concept:**

Diabetic nephropathy is a microvascular complication of diabetes that leads to kidney damage and proteinuria (excess protein excretion in urine). Targeting the renin-angiotensin-aldosterone system (RAAS) and reducing urinary albumin excretion rate (UAE) are key strategies for retarding diabetic nephropathy